Page last updated: 2024-09-05

organophosphonates and African Lymphoma

organophosphonates has been researched along with African Lymphoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Gräler, MH; Guntinas-Lichius, O; Jeya Paul, J; Thuy, AV; Weigel, C; Ziegler, AC1
Chen, Z; Lin, B; Liu, J; Qian, X; Xu, Y; Zhang, H1
Abdulkarim, B; Bourhis, J; Deutsch, E; Frascogna, V; Joab, I; Klijanienko, J; Sabri, S; Vainchenker, W; Zelenika, D1
Agbalika, F; Hocqueloux, L; Molina, JM; Oksenhendler, E1

Other Studies

4 other study(ies) available for organophosphonates and African Lymphoma

ArticleYear
Validation of a monoclonal antibody directed against the human sphingosine 1-phosphate receptor type 1.
    Journal of immunological methods, 2021, Volume: 490

    Topics: Anilides; Animals; Antibodies, Monoclonal; B-Lymphocytes; Burkitt Lymphoma; Endothelial Cells; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Immunoglobulin M; Mice; Organ Specificity; Organophosphonates; Palatine Tonsil; Sphingosine-1-Phosphate Receptors; T-Lymphocytes

2021
7-b, a novel amonafide analogue, cause growth inhibition and apoptosis in Raji cells via a ROS-mediated mitochondrial pathway.
    Leukemia research, 2011, Volume: 35, Issue:5

    Topics: Adenine; Antineoplastic Agents; Apoptosis; Burkitt Lymphoma; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Drug Evaluation, Preclinical; Humans; Mitochondria; Models, Biological; Naphthalimides; Necrosis; Organophosphonates; Reactive Oxygen Species; Signal Transduction

2011
Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
    Oncogene, 2003, Apr-17, Volume: 22, Issue:15

    Topics: Animals; Antiviral Agents; Apoptosis; bcl-2-Associated X Protein; Burkitt Lymphoma; Carcinoma; Caspase 3; Caspase 9; Caspases; Cell Division; Cidofovir; Combined Modality Therapy; Cytosine; Enzyme Activation; Epstein-Barr Virus Infections; Female; Gene Expression Regulation, Viral; Genes, bcl-2; Herpesvirus 4, Human; Humans; Mice; Mice, Nude; Nasopharyngeal Neoplasms; Oncogene Proteins, Viral; Organophosphonates; Organophosphorus Compounds; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Radiation Tolerance; Remission Induction; Tumor Cells, Cultured; Tumor Stem Cell Assay; Tumor Virus Infections; Viral Matrix Proteins; Xenograft Model Antitumor Assays

2003
Long-term remission of an AIDS-related primary effusion lymphoma with antiviral therapy.
    AIDS (London, England), 2001, Jan-26, Volume: 15, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Burkitt Lymphoma; Cidofovir; Cytosine; Herpesvirus 4, Human; Herpesvirus 8, Human; HIV Long-Term Survivors; HIV Protease Inhibitors; Humans; Interferon-alpha; Lymphoma, B-Cell; Male; Organophosphonates; Organophosphorus Compounds; Pleural Effusion; Sarcoma, Kaposi; Time Factors

2001